CV Risk Factors, Atherosclerosis May Alter Brain Metabolism
THURSDAY, March 4, 2021 -- Cardiovascular risk is associated with brain hypometabolism in asymptomatic middle-aged individuals with evidence of subclinical atherosclerosis, according to a study published online Feb. 23 in the Journal of the American College of Cardiology.
Marta Cortes-Canteli, Ph.D., from Centro Nacional de Investigaciones Cardiovasculares in Madrid, and colleagues examined the association between brain metabolism, subclinical atherosclerosis, and cardiovascular risk factors (CVRFs) in 547 middle-aged asymptomatic individuals with evidence of subclinical atherosclerosis.
The researchers found that global ¹⁸F-fluorodeoxyglucose (FDG) uptake showed an inverse correlation with the 30-year Framingham Risk Score (FRS), which was mainly driven by the presence of hypertension. There was an inverse association between carotid plaque burden and global brain FDG uptake, even after adjusting for the 30-year FRS. The brain areas most strongly affected by hypometabolism linked to 30-year FRS, hypertension, and carotid plaque burden were the parietotemporal regions (angular, supramarginal, and inferior/middle temporal gyri) and the cingulate gyrus.
"These data reinforce the need to control CVRFs early in life in order to potentially reduce the brain's midlife vulnerability to future cognitive dysfunction," the authors write.
Several authors disclosed financial ties to the pharmaceutical and biotechnology industries.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
FRIDAY, April 16, 2021 -- The number of physicians in preventive medicine is unlikely to match the population needs in the United States, according to a study published in the...
TUESDAY, April 13, 2021 -- Higher leisure-time physical activity is associated with reduced major adverse cardiovascular events (MACE) and all-cause mortality risk, while higher...
TUESDAY, April 13, 2021 -- Twice-weekly fish intake is associated with a lower risk for major cardiovascular disease (CVD) and mortality in patients with prior CVD, but not the...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.